Corundum Trust Company’s CME Group CME Stock Holding History

Corundum Trust Company’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-112	Closed	-$30.3K	–	65
2025 Q3	$30.3K	Buy	+112	New	+$30.5K	0.07%	89

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Corundum Trust Company's CME Position: Q4 2025 in Review

Corundum Trust Company sold out of CME Group (CME) in Q4 2025, closing a stake of 112 shares — an estimated $30.3K sold.

Corundum Trust Company first reported a position in CME in Q3 2025 and held it in 1 quarter. The position peaked at $30.3K in Q3 2025. 1,732 funds tracked by Wall St. Rank hold CME as of Q4 2025.

Corundum Trust Company reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
Corundum Trust Company sold 112 CME Group shares in Q4 2025, an estimated $30.3K.
Corundum Trust Company first reported a position in CME Group in Q3 2025 and held it in 1 quarter.
Corundum Trust Company's CME Group position peaked at $30.3K in Q3 2025.
1,732 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Corundum Trust Company's 13F filing for Q4 2025, filed 20 Jan 2026.